Haemonetics Long Term Debt 2010-2024 | HAE

Haemonetics long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Haemonetics Annual Long Term Debt
(Millions of US $)
2024 $798
2023 $754
2022 $559
2021 $691
2020 $306
2019 $322
2018 $59
2017 $254
2016 $365
2015 $406
2014 $392
2013 $457
2012 $3
2011 $4
2010 $4
2009 $5
Haemonetics Quarterly Long Term Debt
(Millions of US $)
2024-12-31 $1,220
2024-09-30 $1,220
2024-06-30 $1,218
2024-03-31 $798
2023-12-31 $857
2023-09-30 $749
2023-06-30 $751
2023-03-31 $754
2022-12-31 $757
2022-09-30 $760
2022-06-30 $763
2022-03-31 $559
2021-12-31 $633
2021-09-30 $698
2021-06-30 $767
2021-03-31 $691
2020-12-31 $293
2020-09-30 $297
2020-06-30 $297
2020-03-31 $306
2019-12-31 $310
2019-09-30 $314
2019-06-30 $318
2019-03-31 $322
2018-12-31 $327
2018-09-30 $331
2018-06-30 $331
2018-03-31 $59
2017-12-31 $119
2017-09-30 $178
2017-06-30 $237
2017-03-31 $254
2016-12-31 $270
2016-09-30 $337
2016-06-30 $353
2016-03-31 $365
2015-12-31 $381
2015-09-30 $388
2015-06-30 $399
2015-03-31 $406
2014-12-31 $421
2014-09-30 $428
2014-06-30 $429
2014-03-31 $392
2013-12-31 $406
2013-09-30 $421
2013-06-30 $448
2013-03-31 $457
2012-12-31 $468
2012-09-30 $477
2012-06-30 $3
2012-03-31 $3
2011-12-31 $3
2011-09-30 $3
2011-06-30 $4
2011-03-31 $4
2010-12-31 $4
2010-09-30 $4
2010-06-30 $4
2010-03-31 $4
2009-12-31 $5
2009-09-30 $5
2009-06-30 $5
2009-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.532B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $234.530B 28.20
Boston Scientific (BSX) United States $156.881B 39.27
Stryker (SYK) United States $150.466B 31.46
EssilorLuxottica (ESLOY) France $133.537B 0.00
Medtronic (MDT) Ireland $110.863B 16.19
Lonza Group Ag (LZAGY) Switzerland $49.634B 0.00
Haleon (HLN) United Kingdom $48.673B 27.69
ResMed (RMD) United States $36.905B 27.72
GE HealthCare Technologies (GEHC) United States $33.485B 15.90
Agilent Technologies (A) United States $32.436B 21.43
Terumo (TRUMY) Japan $27.642B 35.90
Insulet (PODD) United States $22.854B 89.71
Koninklijke Philips (PHG) Netherlands $22.587B 16.24
Zimmer Biomet Holdings (ZBH) United States $19.181B 12.32
Baxter (BAX) United States $16.247B 12.13
Smith & Nephew SNATS (SNN) United Kingdom $12.648B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.231B 0.00
Bio-Rad Laboratories (BIO) United States $6.767B 23.55
Lantheus Holdings (LNTH) United States $5.621B 14.18
Prestige Consumer Healthcare (PBH) United States $4.402B 19.67
Perrigo (PRGO) Ireland $3.719B 9.43
ICU Medical (ICUI) United States $3.480B 25.66
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.097B 25.73
QuidelOrtho (QDEL) United States $2.263B 15.56
GN Store Nord (GNNDY) Denmark $2.097B 17.37
LeMaitre Vascular (LMAT) United States $1.915B 42.81
AtriCure (ATRC) United States $1.619B 0.00
Neogen (NEOG) United States $1.435B 18.36
Kestra Medical Technologies (KMTS) United States $1.264B 0.00
AdaptHealth (AHCO) United States $1.217B 12.36
Green Thumb Industries (GTBIF) United States $1.182B 26.59
BioLife Solutions (BLFS) United States $1.121B 0.00
InMode (INMD) Israel $1.020B 9.34
Phibro Animal Health (PAHC) United States $0.973B 12.44
CeriBell (CBLL) United States $0.649B 0.00
Evolus (EOLS) United States $0.625B 0.00
Owens & Minor (OMI) United States $0.570B 4.73
Curaleaf Holdings (CURLF) Canada $0.553B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.535B 0.00
Valneva SE (VALN) France $0.524B 0.00
Tilray Brands (TLRY) Canada $0.498B 0.00
Capricor Therapeutics (CAPR) United States $0.431B 0.00
Surmodics (SRDX) United States $0.409B 0.00
SNDL (SNDL) Canada $0.355B 0.00
Cresco Labs (CRLBF) United States $0.335B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.94
SEMPERIT AG HLD (SEIGY) Austria $0.321B 0.00
Canopy Growth (CGC) Canada $0.305B 0.00
Aurora Cannabis (ACB) Canada $0.288B 51.30
Sanara MedTech (SMTI) United States $0.280B 0.00
Sanuwave Health (SNWV) United States $0.276B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.53
Cerus (CERS) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.251B 11.40
Verano Holdings (VRNOF) United States $0.235B 0.00
Biote (BTMD) United States $0.224B 6.31
High Tide (HITI) Canada $0.191B 0.00
Omeros (OMER) United States $0.188B 0.00
Brainsway (BWAY) Israel $0.187B 49.55
Quanterix (QTRX) United States $0.186B 0.00
Organigram Global (OGI) Canada $0.182B 0.00
OraSure Technologies (OSUR) United States $0.182B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.58
TriSalus Life Sciences (TLSI) United States $0.166B 0.00
FitLife Brands (FTLF) United States $0.128B 0.00
Exagen (XGN) United States $0.128B 0.00
Jin Medical (ZJYL) China $0.125B 0.00
TerrAscend (TSNDF) Canada $0.113B 0.00
Agape ATP (ATPC) $0.103B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.080B 10.32
Veru (VERU) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
Quipt Home Medical (QIPT) United States $0.061B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
Apyx Medical (APYX) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.039B 13.35
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Allurion Technologies (ALUR) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 30.86
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00